LRMR insider filings
Larimar Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-18. Screen LRMR transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 11 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 9 legs across 9 filings by 9 insiders — 147,421 shares, $402,143 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 2.
- Largest priced transaction: purchase of 70,000 shares @ $2.67 ($187,082) by Hamilton Thomas Edward, filed 2026-11-12.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Hamilton Thomas Edward — Director | 1 | 1 leg · 70,000 sh · $187,082 | — | — |
| Celano Michael — Chief Financial Officer | 1 | 1 leg · 18,460 sh · $49,992 | — | — |
| BEN-MAIMON CAROLE — President and CEO, Director | 1 | 1 leg · 18,050 sh · $49,953 | — | — |
| Harlow John B. Jr. — President and COO | 3 | 1 leg · 17,800 sh · $49,918 | — | 2 |
| THOMAS FRANK E — Director | 1 | 1 leg · 8,000 sh · $21,800 | — | — |
| Shankar Gopi — Chief Development Officer | 1 | 1 leg · 5,000 sh · $13,549 | — | — |
| SHERMAN JEFFREY W — Director | 1 | 1 leg · 3,289 sh · $10,058 | — | — |
| Clayton Russell — Chief Medical Officer | 1 | 1 leg · 3,322 sh · $9,999 | — | — |
| Truitt Joseph — Director | 1 | 1 leg · 3,500 sh · $9,792 | — | — |
Recent insider filings — Larimar Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | Clayton Russell — Chief Medical Officer | Purchase (P): 3,322 @ $3.01 | EDGAR |
| 2026-11-16 | 4 | SHERMAN JEFFREY W — Director | Purchase (P): 3,289.47 @ $3.06 | EDGAR |
| 2026-11-12 | 4 | Hamilton Thomas Edward — Director | Purchase (P): 70,000 @ $2.67 | EDGAR |
| 2026-11-12 | 4 | BEN-MAIMON CAROLE — President and CEO, Director | Purchase (P): 18,050 @ $2.77 | EDGAR |
| 2026-11-12 | 4 | Truitt Joseph — Director | Purchase (P): 3,500 @ $2.80 | EDGAR |
| 2026-11-12 | 4 | THOMAS FRANK E — Director | Purchase (P): 8,000 @ $2.73 | EDGAR |
| 2026-11-12 | 4 | Harlow John B. Jr. — President and COO | Purchase (P): 17,800 @ $2.80 | EDGAR |
| 2026-11-12 | 4 | Celano Michael — Chief Financial Officer | Purchase (P): 18,460 @ $2.71 | EDGAR |
| 2026-11-12 | 4 | Shankar Gopi — Chief Development Officer | Purchase (P): 5,000 @ $2.71 | EDGAR |
| 2026-10-01 | 3 | Harlow John B. Jr. — President and COO | Holdings only — no transactions reported | EDGAR |
| 2026-10-01 | 4 | Harlow John B. Jr. — President and COO | Grant/award (A): 50,000 @ $0 · Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2026-07-08 | 4 | Hamilton Thomas Edward — Director | Purchase (P): 50,000 @ $3.34 | EDGAR |
| 2026-05-20 | 4 | Truitt Joseph — Director | Grant/award (A): 55,150 (derivative) @ $0 | EDGAR |
| 2026-05-20 | 4 | Hamilton Thomas Edward — Director | Grant/award (A): 55,150 (derivative) @ $0 | EDGAR |
| 2026-05-20 | 4 | THOMAS FRANK E — Director | Grant/award (A): 55,150 (derivative) @ $0 | EDGAR |
| 2026-05-20 | 4 | SHERMAN JEFFREY W — Director | Grant/award (A): 55,150 (derivative) @ $0 | EDGAR |
| 2026-05-20 | 4 | LEFF JONATHAN S — Director | Grant/award (A): 55,150 (derivative) @ $0 | EDGAR |
| 2026-05-20 | 4 | Flynn James E — Director, 10% owner DEERFIELD MANAGEMENT COMPANY, L.P. — Director, 10% owner | Grant/award (A): 55,150 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | Hamilton Thomas Edward — Director | Purchase (P): 100,000 @ $5 | EDGAR |
| 2026-03-02 | 4 | THOMAS FRANK E — Director | Purchase (P): 5,000 @ $5 | EDGAR |
| 2026-03-02 | 4 | SHERMAN JEFFREY W — Director | Purchase (P): 5,000 @ $5 | EDGAR |
| 2026-03-02 | 4 | Flynn James E — Director, 10% owner DEERFIELD MANAGEMENT COMPANY, L.P. — Director, 10% owner Deerfield Mgmt III, L.P. — Director, 10% owner Deerfield Mgmt HIF, L.P. — Director, 10% owner Deerfield Mgmt IV, L.P. — Director, 10% owner Deerfield Mgmt L.P. — Director, 10% owner Deerfield Private Design Fund III, L.P. — Director, 10% owner Deerfield Healthcare Innovations Fund, L.P. — Director, 10% owner Deerfield Private Design Fund IV, L.P. — Director, 10% owner DEERFIELD PARTNERS, L.P. — Director, 10% owner | Purchase (P): 1,084,010 @ $5 · Purchase (P): 1,084,012 @ $5 · Purchase (P): 831,978 @ $5 · Purchase (P): 2,000,000 @ $5 | EDGAR |
| 2026-01-27 | 4 | Shankar Gopi — Chief Development Officer | Grant/award (A): 25,637 @ $0 · Grant/award (A): 153,822 (derivative) @ $0 | EDGAR |
| 2026-01-27 | 4 | Clayton Russell — Chief Medical Officer | Grant/award (A): 25,637 @ $0 · Grant/award (A): 153,822 (derivative) @ $0 | EDGAR |
| 2026-01-27 | 4 | BEN-MAIMON CAROLE — President and CEO, Director | Grant/award (A): 100,100 @ $0 · Grant/award (A): 600,600 (derivative) @ $0 | EDGAR |
| 2026-01-27 | 4 | Celano Michael — Chief Financial Officer | Grant/award (A): 37,604 @ $0 · Grant/award (A): 225,622 (derivative) @ $0 | EDGAR |
| 2025-08-04 | 4 | Flynn James E — Director, 10% owner DEERFIELD MANAGEMENT COMPANY, L.P. — Director, 10% owner Deerfield Mgmt III, L.P. — Director, 10% owner Deerfield Mgmt HIF, L.P. — Director, 10% owner Deerfield Mgmt IV, L.P. — Director, 10% owner Deerfield Mgmt L.P. — Director, 10% owner Deerfield Private Design Fund III, L.P. — Director, 10% owner Deerfield Healthcare Innovations Fund, L.P. — Director, 10% owner Deerfield Private Design Fund IV, L.P. — Director, 10% owner DEERFIELD PARTNERS, L.P. — Director, 10% owner | Purchase (P): 3,387,529 @ $3.20 · Purchase (P): 3,387,539 @ $3.20 · Purchase (P): 2,599,932 @ $3.20 | EDGAR |
| 2025-05-15 | 4 | Flynn James E — Director, 10% owner DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) — Director, 10% owner | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-05-14 | 4 | Truitt Joseph — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-05-14 | 4 | Hamilton Thomas Edward — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-05-14 | 4 | THOMAS FRANK E — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-05-14 | 4 | SHERMAN JEFFREY W — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-05-14 | 4 | LEFF JONATHAN S — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4 | Shankar Gopi — Chief Development Officer | Grant/award (A): 23,306 @ $0 · Grant/award (A): 139,838 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4 | Clayton Russell — Chief Medical Officer | Grant/award (A): 23,306 @ $0 · Grant/award (A): 139,838 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4 | BEN-MAIMON CAROLE — President and CEO, Director | Grant/award (A): 91,000 @ $0 · Grant/award (A): 546,000 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4 | Celano Michael — Chief Financial Officer | Grant/award (A): 34,185 @ $0 · Grant/award (A): 205,111 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | Flynn James E — Director, 10% owner DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) — Director, 10% owner | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2024-05-31 | 4 | Truitt Joseph — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2024-05-31 | 4 | Hamilton Thomas Edward — Director | Purchase (P): 57,208 @ $8.74 · Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2024-05-31 | 4 | THOMAS FRANK E — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2024-05-31 | 4 | SHERMAN JEFFREY W — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2024-05-31 | 4 | LEFF JONATHAN S — Director | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Flynn James E — Director, 10% owner DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) — Director, 10% owner Deerfield Mgmt III, L.P. — Director, 10% owner Deerfield Mgmt HIF, L.P. — Director, 10% owner Deerfield Mgmt IV, L.P. — Director, 10% owner Deerfield Mgmt L.P. — Director, 10% owner Deerfield Private Design Fund III, L.P. — Director, 10% owner Deerfield Healthcare Innovations Fund, L.P. — Director, 10% owner Deerfield Private Design Fund IV, L.P. — Director, 10% owner DEERFIELD PARTNERS, L.P. — Director, 10% owner | Purchase (P): 1,430,206 @ $8.74 · Purchase (P): 1,430,206 @ $8.74 · Purchase (P): 1,430,205 @ $8.74 | EDGAR |
| 2024-02-15 | 4 | THOMAS FRANK E — Director | Purchase (P): 2,000 @ $11 | EDGAR |
| 2024-01-19 | 4 | Shankar Gopi — Chief Development Officer | Grant/award (A): 22,500 @ $0 · Grant/award (A): 135,000 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | Celano Michael — Chief Financial Officer | Grant/award (A): 31,250 @ $0 · Grant/award (A): 187,500 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | Clayton Russell — Chief Medical Officer | Grant/award (A): 22,500 @ $0 · Grant/award (A): 135,000 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | BEN-MAIMON CAROLE — President and CEO, Director | Grant/award (A): 66,125 @ $0 · Grant/award (A): 396,750 (derivative) @ $0 | EDGAR |
| 2023-12-08 | 4 | Shankar Gopi — Chief Development Officer | Purchase (P): 5,000 @ $3.73 | EDGAR |
Recent 8-K events — Larimar Therapeutics, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-16 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-09 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-29 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-08-04 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-29 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-19 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-19 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-09 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=LRMR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs